ArticleNPJ precision oncology2021

Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors.

Marianne Oulhen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.